BankPlus Trust Department Makes New $1.46 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

BankPlus Trust Department acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,884 shares of the healthcare conglomerate’s stock, valued at approximately $1,459,000.

Several other institutional investors and hedge funds also recently bought and sold shares of UNH. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the 3rd quarter valued at about $37,000. DecisionPoint Financial LLC increased its position in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after acquiring an additional 62 shares during the last quarter. Highline Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $55,000. Finally, Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group in the third quarter valued at approximately $57,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $465.58 on Monday. The stock’s 50-day moving average price is $519.27 and its 200 day moving average price is $560.44. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market capitalization of $428.46 billion, a PE ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the firm posted $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on UNH shares. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.